Funded Startups in Valbonne
Across the 6 most recent Valbonne entries shown, the disclosed maximum is TSE’s $104M round (2025-01-20), which dwarfs the next-largest disclosed amount, M…
Across the 6 most recent Valbonne entries shown, the disclosed maximum is TSE’s $104M round (2025-01-20), which dwarfs the next-largest disclosed amount, Median Technologies’ $58M (2026-06-03). The smaller rounds cluster much closer together: NicOx at $7M (2026-06-22) and BiOceanOr at $2M (2023-07-14) sit at the low end, while MYCOPHYTO’s $19M (2026-01-12) and FLEX-O’s $18M (2021-03-22) bracket the mid-teens.
Stage labels are highly uneven, with 4 of 6 rows marked “Series Unknown” (NicOx 2026-06-22 $7M; Median Technologies 2026-06-03 $58M; TSE 2025-01-20 $104M; BiOceanOr 2023-07-14 $2M). Temporally, these rounds span from FLEX-O’s 2021-03-22 Pre-Seed to NicOx’s 2026-06-22 Series Unknown, with a noticeable concentration in 2025–2026 (3 of 6 entries). Sector-wise, each listed category appears once except the presence of “Health Care” (Median Technologies) and “Energy” (TSE), each represented by a single company in this slice.
Most recent rounds
6 shownRelated listings
Frequently asked
Which Valbonne round is the clearest outlier by disclosed size, and how does it compare to the rest of the list?
TSE’s $104M (2025-01-20) is the largest disclosed amount in the 6-row slice and sits well above the next-largest, Median Technologies at $58M (2026-06-03). The remaining disclosed amounts range from $19M (MYCOPHYTO, 2026-01-12) and $18M (FLEX-O, 2021-03-22) down to $7M (NicOx, 2026-06-22) and $2M (BiOceanOr, 2023-07-14).
How concentrated are these rounds in the most recent time window?
Half of the entries fall in 2025–2026: TSE ($104M, 2025-01-20), MYCOPHYTO ($19M, 2026-01-12), Median Technologies ($58M, 2026-06-03), and NicOx ($7M, 2026-06-22) account for 4 of 6 rows. The earliest shown is FLEX-O’s 2021-03-22 Pre-Seed ($18M).
Are stage labels over-represented, suggesting limited disclosure in this set?
Yes. “Series Unknown” appears in 4 of 6 rows: NicOx ($7M, 2026-06-22), Median Technologies ($58M, 2026-06-03), TSE ($104M, 2025-01-20), and BiOceanOr ($2M, 2023-07-14). The remaining two labels are MYCOPHYTO as Series A ($19M, 2026-01-12) and FLEX-O as Pre-Seed ($18M, 2021-03-22).
Do any sectors cluster, or is the sector mix evenly spread across categories?
In this 6-row view, sectors do not repeat: Biotechnology (NicOx), Health Care (Median Technologies), Agriculture and Farming (MYCOPHYTO), Energy (TSE), Natural Resources (BiOceanOr), and Real Estate (FLEX-O) each appear once. That makes the sector mix fragmented rather than concentrated.
Which entries fall near the low end of disclosed amounts, and do they align with any stage pattern?
The smallest disclosed amounts are BiOceanOr at $2M (2023-07-14, Series Unknown) and NicOx at $7M (2026-06-22, Series Unknown). Both low-end entries share the same stage label category (“Series Unknown”), while the only non-Unknown rounds are MYCOPHYTO ($19M, Series A) and FLEX-O ($18M, Pre-Seed).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.